Label-free and early detection of HER2 breast cancer biomarker based on UiO-66-NH 2 modified gold chip (Au/UiO-66-NH 2 ) using surface plasmon resonance technique

Lena Rahmidar,Gilang Gumilar,Ni Luh Wulan Septiani,Chandra Wulandari,Muhammad Iqbal,Nugraha,Shofarul Wustoni,Brian Yuliarto
DOI: https://doi.org/10.1016/j.microc.2024.109963
IF: 5.304
2024-01-20
Microchemical Journal
Abstract:Breast cancer is one of the leading causes of cancer death for women worldwide. This cancer occurs when the breast cells grow abnormally and spread uncontrolled. Although there are several treatments, including chemotherapy, radiation, and surgery in a clinical setting to cure cancer, these treatments cannot provide a 100 % success rate in eliminating cancer, mainly due to the late diagnosis of the disease. Thus, early detection is the key to provide better breast cancer treatment and a higher chance for survival. Herein, simple and sensitive biosensor by combining the emerging multifunctional materials of metal-organic frameworks (MOFs) with a label-free surface plasmon resonance (SPR) instrument was developed. Two types of stable Zirconium (Zr)-based MOFs, namely Zr benzene dicarboxylic acid (Zr-BDC or UiO-66) and Zr 2-amino-benzene dicarboxylic acid (Zr-BDC-NH 2 or UiO-66-NH 2 ) were synthesized using the solvothermal method. X-ray diffractometer (XRD) and fourier transform infra red (FTIR) confirmed the formation of the prepared UiO-66 and UiO-66-NH 2 . The electron microscopy and nitrogen adsorption desorption isotherm characterization reveal that the MOFs have a cubic crystal structure with a high surface area of 672.4 m 2 /g for UiO-66 and 286.1 m 2 /g for UiO-66-NH 2 . The MOFs are then functionalized on the SPR gold (Au) chip surface to serve as a matrix of Human Epidermal Growth Factor Receptor 2 (HER2) antibody receptors. Interestingly, the functionalized SPR biosensors could detect the HER2 protein target with high sensitivity in the ng/mL range and a remarkable detection limit, which is 0.457 ng/mL for UiO-66-NH 2 . This LOD value is significantly lower than clinical concentrations of HER2 proteins in human blood (∼15 ng/mL), which indicate that the biosensor can offer the capability of early detection test.
chemistry, analytical
What problem does this paper attempt to address?